Skip to content
AwardedSpainGoods

Suministro del principio activo denominado PERTUZUMAB/TRASTUZUMAB VIAL SUBCUTÁNEO (PHESGO), para el Servicio de Farmacia delComplejo Hospitalario Universitario de Canarias.

Published
Published 25 March 2025

Overview

Realización del suministro del principio activo denominado PERTUZUMAB/TRASTUZUMAB VIAL SUBCUTÁNEO (PHESGO), para el Servicio deFarmacia del Complejo Hospitalario Universitario de Canarias, con el fin de atender las necesidades derivadas de la actividadhabitual de este Centro Sanitario y que están previstas presupuestariamente como gasto corriente, estando aprobado como nuevofármaco y financiado por el Sistema Nacional de Salud, y que se requiere para el uso en pacientes del Servicio Canario de laSalud.

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Direct
Published
25 March 2025
Classification (CPV)
Various medicinal products

Award outcome

Awarded value
€1,405,590
Award date
18 February 2025
Winner
  • ROCHE FARMA SA

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    25 March 2025

Contracting authority

  • Consejería de Sanidad del Gobierno de Canarias

    Procuring entity

    Las Palmas de Gran Canaria, Spain

    ID_PLATAFORMA: 21058420149602

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro del principio activo denominado PERTUZUMAB/TRASTUZUMAB VIAL SUBCUTÁNEO (PHESGO), para el Servicio de Farmacia delComplejo Hospitalario Universitario de Canarias. — won by ROCHE FARMA SA — Skim